טוען...
Teriflunomide treatment reduces B cells in patients with MS
OBJECTIVE: To study the immunomodulatory effect of teriflunomide on innate and adaptive immune cell populations through a pilot, open-label, observational study in a cohort of patients with relapsing-remitting MS. METHODS: Blood lymphocytes were isolated from 10 patients with MS before and after 3 o...
שמור ב:
| הוצא לאור ב: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Lippincott Williams & Wilkins
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5656406/ https://ncbi.nlm.nih.gov/pubmed/29082295 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000403 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|